CareDx

CareDx, Inc. is a precision medicine company dedicated to improving the lives of transplant patients and their caregivers through innovative healthcare solutions. The company specializes in genomics-based diagnostics, offering a range of products including AlloSure Kidney, a non-invasive test that measures donor-derived cell-free DNA in kidney transplant patients, and AlloMap Heart, a gene expression profiling test for heart transplant recipients. CareDx also provides additional solutions such as Olerup SSP and TruSight HLA for human leukocyte antigen typing, AlloSeq cfDNA for post-transplant monitoring, and various software solutions for transplant administration. These products support the entire transplant journey, from initial donor-recipient matching to ongoing patient care and monitoring. CareDx markets its services directly to healthcare providers and through third-party distributors, and it has established partnerships for the development of advanced diagnostic technologies. The company, originally named XDx, Inc., was founded in 1998 and is headquartered in South San Francisco, California.

Kim Clark-Langone

VP, New Product Development

Michelle Foley

VP Transplant Software Operations

Reginald Seeto

Founder, President and CEO

Mitchell Nelles Ph.D

COO

8 past transactions

Transplant Hero

Acquisition in 2021
Transplant Hero is a provider of mobile applications supporting the needs of transplant patients. Transplant Hero provides a smartphone app focused on helping transplant patients manage their medications through alarms and interactive logging of medication events.

Miromatrix Medical

Series C in 2021
Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care. It was founded in 2009 and is based in Eden Prairie, Minnesota.

BFS Molecular

Acquisition in 2021
BFS Molecular is a global molecular diagnostics company intent on transforming and improving the way post-transplantation patient care is practiced.

TransChart

Acquisition in 2021
TransChart offers support for the transplant of kidney, heart, lung, liver, pancreas (Islet Cell), and small bowel.

XynManagement

Acquisition in 2019
XynManagement is a provider of solutions to simplify transplant quality tracking and waitlist management. XynManagement solutions address the key problems facing transplant centers today. Through the XynQAPI, we enable transplant professionals to assess candidate and donor risk, track and monitor center-level performance in real time, and enhance patient care.

OTTR Chronic Care Solutions

Acquisition in 2019
OTTR has provided transplant software solutions that improve the quality of patient care via workflow management to reduce operational costs. Today, they are the leading provider of organ transplant patient tracking software. OTTR serves over 200 programs at more than 60 transplant centers in the United States and Canada, and they also offer their solutions in the U.K., Saudi Arabia and Australia.

Allenex

Acquisition in 2015
Allenex AB (publ), a life science company, develops, manufactures, markets, and sells products for transplantation of blood stem cells and organs worldwide. The company develops kits for genomic Human Leukocyte Antigens (HLA) typing used prior to hematopoietic stem cell/bone marrow transplantation and organ transplantation to match the donor and recipient; and XM-ONE, products and services for organ transplantation. Its research portfolio includes AB0 column for transplantations between people of different blood groups; and an AB0 diagnostic test that measures the occurrence of blood group antibodies. Allenex AB (publ) sells its products through sub-distributors primarily to laboratories active in transplantation diagnostics. The company was formerly known as LinkMed AB and changed its name to Allenex AB in June 2011. Allenex AB (publ) was founded in 1998 and is headquartered in Stockholm, Sweden.

ImmuMetrix

Acquisition in 2014
ImmuMetrix, Inc. operates as a biotechnology company. ImmuMetrix, Inc. was incorporated in 2010 and is based in Palo Alto, California.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.